WASHINGTON — The White House is reviewing a proposal that could shake up the system that allows drug makers to offer rebates to pharmacy benefit managers, a shift that some U.S. officials hope could drive down the prices of medicines.

Currently, pharmaceutical companies set list prices for drugs and then offer PBMs (which work for insurers) rebates off list prices if an insurer covers those drugs. Drug manufacturers have alleged that PBMs demand large rebates, forcing them to increase list prices to make sure they can still profit.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Look at history . Drug manufacturers charge what the market will bear . History shows competition drives prices down . With only three PBMs ( Express Scripts , CVS / Caremark , OptumRX ) controlling the vast majority of prescriptions filled – there is no competition . Drug manufacturers take advantage and charge as much as they can .

  • PBM monopolize and dictate patients to go to certain pharmacies, for example CVS caremark. They restrict a 90 days fill often below cost reimbursement to independent pharmacies. They audit and find minor faults for claw-backs and if you contest, they terminate you off as a provider. They send membership cards with their name only on card, misleading the public that they can only go to their chains. This is false advertisement. They continue to do this driving independent pharmacies out of business. PBM also own part of the 3 big wholesalers . PBM practices should be reviewed, their clout and power are unchecked with no competition. Independent pharmacies are closing every day due to unfair practices by PBM. Any challenges would result in individual pharmacies being terminated from their plan. There is no recourse, they are the final answer to everything. Please help independent pharmacies find justice.

Your daily dose of news in health and medicine

Privacy Policy